{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:59:40Z","timestamp":1767837580316,"version":"3.49.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Tuberculosis"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijtb.2019.11.012","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T02:25:18Z","timestamp":1574389518000},"page":"389-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum"],"prefix":"10.1016","volume":"67","author":[{"given":"Deepika","family":"Saroha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divyani","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajinder K.","family":"Dhamija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijtb.2019.11.012_bib1","first-page":"347","article-title":"Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis","volume":"7","author":"Shin","year":"2003","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"10.1016\/j.ijtb.2019.11.012_bib2","unstructured":"WHO | Rapid Communication: Key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR\/RR-TB). WHO. http:\/\/www.who.int\/tb\/publications\/2018\/rapid_communications_MDR\/en\/."},{"issue":"1","key":"10.1016\/j.ijtb.2019.11.012_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12941-016-0156-y","article-title":"Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis","volume":"15","author":"Agyeman","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"6","key":"10.1016\/j.ijtb.2019.11.012_bib4","doi-asserted-by":"crossref","first-page":"e1839","DOI":"10.1097\/MJT.0000000000000359","article-title":"Linezolid induced reversible peripheral neuropathy","volume":"23","author":"Vishnu","year":"2016","journal-title":"Am J Therapeut"},{"issue":"24","key":"10.1016\/j.ijtb.2019.11.012_bib5","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2169\/internalmedicine.1344-18","article-title":"Is severe and long-lasting linezolid-induced optic neuropathy reversible?","volume":"57","author":"Lee","year":"2018","journal-title":"Intern Med Tokyo Jpn"},{"issue":"8","key":"10.1016\/j.ijtb.2019.11.012_bib6","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/501356","article-title":"Linezolid-induced inhibition of mitochondrial protein synthesis","volume":"42","author":"De Vriese","year":"2006","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"1","key":"10.1016\/j.ijtb.2019.11.012_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1378\/chest.77.1.98","article-title":"Peripheral neuropathy associated with ethambutol","volume":"77","author":"Nair","year":"1980","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ijtb.2019.11.012_bib8","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5588\/ijtld.10.0284","article-title":"Polyneuropathy, anti-tuberculosis treatment and the role of pyridoxine in the HIV\/AIDS era: a systematic review","volume":"15","author":"van der Watt","year":"2011","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"issue":"4","key":"10.1016\/j.ijtb.2019.11.012_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American thoracic society\/centers for Disease Control and prevention\/infectious diseases society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijtb.2019.11.012_bib10","article-title":"Bedaquiline for the treatment of multidrug-resistant tuberculosis in the United States","author":"Mase","year":"2019","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"6","key":"10.1016\/j.ijtb.2019.11.012_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4103\/lungindia.lungindia_141_18","article-title":"Utility of para-aminosalicylic acid in drug-resistant tuberculosis: should it be classified as group D3 or group C?","volume":"35","author":"Desai","year":"2018","journal-title":"Lung India Off Organ Indian Chest Soc"}],"container-title":["Indian Journal of Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570719304482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019570719304482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T03:58:02Z","timestamp":1758081482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019570719304482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0019570719304482"],"URL":"https:\/\/doi.org\/10.1016\/j.ijtb.2019.11.012","relation":{},"ISSN":["0019-5707"],"issn-type":[{"value":"0019-5707","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijtb.2019.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}